Author:
Chen Jie,Cheng Hui,Liang Yujing,Lin Jieyi,Jia Guodong,Wang Tianyi,Li Yifu,Chen Yu,Wang Pan,Shen Bowen,Liu Sailan,Guo Shanshan,Chen Qiuyan,Tang Linquan,Mai Haiqiang,Liu Liting
Reference30 articles.
1. Nasopharyngeal carcinoma;Chen;Lancet,2019
2. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. https://gco.iarc.who.int/today [accessed 14 March 2024].
3. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099;Al-Sarraf;J Clin Oncol,1998
4. Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial;Chen;Lancet,2021
5. Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized Clinical Trial;Miao;JAMA Oncol,2022